Chief Scientific Officer at Kala Pharmaceuticals, a biotech company she helped start in 2010. At Kala, Chen successfully translated a novel nanoparticle technology from bench discovery into late stage human clinical trials, and has helped to attract more than $150 million in investments to the company. In 2014, Mass High Tech named Dr. Chen as one of its Women to Watch, an award recognizing women who are shaping the future of the life sciences industry. Chen earned her B.S. degree from Texas ChE in 1992, later earning her M.S. and Sc.D. degrees in chemical engineering from Massachusetts Institute of Technology.
Chief Scientific Officer at Kala Pharmaceuticals, a biotech company she helped start in 2010. At Kala, Chen successfully translated a novel nanoparticle technology from bench discovery into late stage human clinical trials, and has helped to attract more than $150 million in investments to the company. In 2014, Mass High Tech named Dr. Chen as one of its Women to Watch, an award recognizing women who are shaping the future of the life sciences industry. Chen earned her B.S. degree from Texas ChE in 1992, later earning her M.S. and Sc.D. degrees in chemical engineering from Massachusetts Institute of Technology.